Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.3.0.15
Consolidated Balance Sheets (USD $)
In Thousands
Sep. 30, 2011
Dec. 31, 2010
Current assets:    
Cash and cash equivalents of continuing operations $ 451,657 $ 433,914
Cash and cash equivalents of discontinued operations   252
Total cash and cash equivalents 451,657 434,166
Premium and related receivables, net of allowance for uncollectible accounts of $592 and $17, respectively 139,467 136,243
Short-term investments, at fair value (amortized cost $104,914 and $21,141, respectively) 106,344 21,346
Other current assets 68,908 64,154
Current assets of discontinued operations other than cash   912
Total current assets 766,376 656,821
Long-term investments, at fair value (amortized cost $521,229 and $585,862, respectively) 530,452 595,879
Restricted deposits, at fair value (amortized cost $26,697 and $22,755, respectively) 26,768 22,758
Property, software and equipment, net of accumulated depreciation of $166,442 and $138,629, respectively 345,600 326,341
Goodwill 281,981 278,051
Intangible assets, net 28,795 29,109
Other long-term assets 57,526 30,057
Long-term assets of discontinued operations   4,866
Total assets 2,037,498 1,943,882
Current liabilities:    
Medical claims liability 498,705 456,765
Accounts payable and accrued expenses 173,708 185,218
Unearned revenue 54,764 117,344
Current portion of long-term debt 3,203 2,817
Current liabilities of discontinued operations   3,102
Total current liabilities 730,380 765,246
Long-term debt 348,093 327,824
Other long-term liabilities 54,926 53,378
Long-term liabilities of discontinued operations   379
Total liabilities 1,133,399 1,146,827
Commitments and contingencies    
Stockholders' equity:    
Common stock, $.001 par value; authorized 100,000,000 shares; 52,921,255 issued and 50,377,774 outstanding at September 30, 2011, and 52,172,037 issued and 49,616,824 outstanding at December 31, 2010 53 52
Additional paid-in capital 411,924 384,206
Accumulated other comprehensive income:    
Unrealized gain on investments, net of tax 6,478 6,424
Retained earnings 534,849 453,743
Treasury stock, at cost (2,543,481 and 2,555,213 shares, respectively) (50,594) (50,486)
Total Centene stockholders' equity 902,710 793,939
Noncontrolling interest 1,389 3,116
Total stockholders' equity 904,099 797,055
Total liabilities and stockholders' equity $ 2,037,498 $ 1,943,882